AKT1 and non-small cell lung carcinoma: This suggests that miR-424-5p suppress the expression of SOCS5 and SOCS6 to activate JAK2/STAT3 and PI3K/AKT pathways, which is responsible for the promotion of NSCLC growth and DDP resistance.